Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AbbVie Inc. | EVP, CHIEF FINANCIAL OFFICER | Common Stock, $0.01 par value | 15.4K | $2.76M | $178.99 | Feb 28, 2024 | Direct |
AbbVie Inc. | EVP, CHIEF FINANCIAL OFFICER | Option (Right to buy) | 17.4K | $1.07M | $61.36 | Feb 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABBV | AbbVie Inc. | Feb 23, 2024 | 4 | -$4.59M | 4 | Mar 1, 2024 | EVP, CHIEF FINANCIAL OFFICER |
ABBV | AbbVie Inc. | Feb 15, 2024 | 5 | $0 | 4 | Feb 20, 2024 | EVP, CHIEF FINANCIAL OFFICER |
ABBV | AbbVie Inc. | Feb 28, 2023 | 3 | -$4.4M | 4 | Mar 2, 2023 | EVP, CHIEF FINANCIAL OFFICER |
ABBV | AbbVie Inc. | Feb 16, 2023 | 5 | $0 | 4 | Feb 21, 2023 | EVP, CHIEF FINANCIAL OFFICER |
ABBV | AbbVie Inc. | Jun 28, 2022 | 0 | $0 | 3 | Jul 8, 2022 | SVP, Chief Financial Officer |